It can arise from a variety of mechanisms, including signaling pathway mutations, decreased neoantigen expression, upregulation of alternative immune checkpoints, elevated PD-L1 expression, T-cell exhaustion, metabolic changes in the tumor microenvironment, or immunosuppressive cell recruitment [71]. The gene discussed is CD274; the disease is neoplasm.